The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.
wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Tommaso M. De Pas

Medical Oncology Unit of Respiratory Tract and Sarcomas

New Drugs Development Division

European Institute of Oncology

Via Ripamonti 435

Italy;

[email]@ieo.it

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Medical Oncology Unit of Respiratory Tract and Sarcomas, New Drugs Development Division, European Institute of Oncology, Via Ripamonti 435, Italy;. 2011
  • New Drugs Development and Clinical Pharmacology Unit, Department of Medicine, European Institute of Oncology, Milan, Italy. 2008 - 2010
  • New Drugs Development Unit, European Institute of Oncology, Milan, Italy. 2000 - 2008
  • New Drugs Development Unit, Italy. 2006

References

  1. Large-Cell Neuroendocrine Carcinoma of the Lung Harboring EGFR Mutation and Responding to Gefitinib. De Pas, T.M., Giovannini, M., Manzotti, M., Trifirò, G., Toffalorio, F., Catania, C., Spaggiari, L., Labianca, R., Barberis, M. J. Clin. Oncol. (2011) [Pubmed]
  2. A critical appraisal of the adjuvant chemotherapy guidelines for patients with completely resected T3N0 non-small-cell lung cancer. De Pas, T., Raimondi, S., Pelosi, G., Spaggiari, L., De Braud, F., Veronesi, G., Maisonneuve, P. Acta. Oncol (2010) [Pubmed]
  3. Brief report: activity of imatinib in a patient with platelet-derived-growth-factor receptor positive malignant solitary fibrous tumor of the pleura. De Pas, T., Toffalorio, F., Colombo, P., Trifirò, G., Pelosi, G., Vigna, P.D., Manzotti, M., Agostini, M., de Braud, F. J. Thorac. Oncol (2008) [Pubmed]
  4. Dendritic cell sarcoma: an analytic overview of the literature and presentation of original five cases. De Pas, T., Spitaleri, G., Pruneri, G., Curigliano, G., Noberasco, C., Luini, A., Andreoni, B., Testori, A., de Braud, F. Crit. Rev. Oncol. Hematol. (2008) [Pubmed]
  5. Oligometastatic non-small cell lung cancer: a multidisciplinary approach in the positron emission tomographic scan era. De Pas, T.M., de Braud, F., Catalano, G., Putzu, C., Veronesi, G., Leo, F., Solli, P.G., Brambilla, D., Paganelli, G., Spaggiari, L. Ann. Thorac. Surg. (2007) [Pubmed]
  6. A proper schedule of weekly paclitaxel and gemcitabine combination is highly active and very well tolerated in NSCLC patients. De Pas, T., Putzu, C., Curigliano, G., Noberasco, C., Boselli, S., Sabrina, B., Catania, C., Orlando, L., Milani, A., Spaggiari, L., de Braud, F. Lung. Cancer (2006) [Pubmed]
  7. Oral administration of vinorelbine can overcome intractable endovenous-vinorelbine-associated acute tumor pain. De Pas, T., Sbanotto, A., Catania, C., Banfi, M.G., Curigliano, G., Nolè, F., Fazio, N., Formica, V., Veronesi, G., de Braud, F. Support. Care. Cancer (2005) [Pubmed]
  8. Modulation of epidermal growth factor receptor status by chemotherapy in patients with locally advanced non-small-cell lung cancer is rare. De Pas, T., Pelosi, G., de Braud, F., Veronesi, G., Curigliano, G., Leon, M.E., Danesi, R., Noberasco, C., d'Aiuto, M., Catalano, G., Viale, G., Spaggiari, L. J. Clin. Oncol. (2004) [Pubmed]
  9. Peptide receptor radiotherapy: a new option for the management of aggressive fibromatosis on behalf of the Italian Sarcoma Group. De Pas, T., Bodei, L., Pelosi, G., De Braud, F., Villa, G., Capanna, R., Paganelli, G. Br. J. Cancer (2003) [Pubmed]
  10. Imatinib administration in two patients with liver metastases from GIST and severe jaundice. De Pas, T., Danesi, R., Catania, C., Curigliano, G., De Braud, F. Br. J. Cancer (2003) [Pubmed]
  11. Phase I study of twelve-day prolonged infusion of high-dose ifosfamide and doxorubicin as first-line chemotherapy in adult patients with advanced soft tissue sarcomas. De Pas, T., Curigliano, G., Masci, G., Catania, C., Comandone, A., Boni, C., Tucci, A., Pagani, O., Marrocco, E., de Braud, F. Ann. Oncol. (2002) [Pubmed]
  12. Cisplatin and vinorelbine as second-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) resistant to taxol plus gemcitabine. De Pas, T., de Braud, F., Mandalà, M., Curigliano, G., Catania, C., Ferretti, G., Sozzi, P., Solli, P., Goldhirsch, A. Lung. Cancer (2001) [Pubmed]
  13. Gemcitabine-induced systemic capillary leak syndrome. De Pas, T., Curigliano, G., Franceschelli, L., Catania, C., Spaggiari, L., de Braud, F. Ann. Oncol. (2001) [Pubmed]
  14. Phase I and pharmacologic study of weekly gemcitabine and paclitaxel in chemo-naïve patients with advanced non-small-cell lung cancer. De Pas, T., de Braud, F., Danesi, R., Sessa, C., Catania, C., Curigliano, G., Fogli, S., del Tacca, M., Zampino, G., Sbanotto, A., Rocca, A., Cinieri, S., Marrocco, E., Milani, A., Goldhirsch, A. Ann. Oncol. (2000) [Pubmed]
 
WikiGenes - Universities